Brief: Chemomab Therapeutics To Discuss Fourth Quarter Results
17/03/2023 11:05
March 17 (Reuters) - Chemomab Therapeutics Ltd CMMB.O :
* CHEMOMAB THERAPEUTICS TO DISCUSS FOURTH QUARTER AND
FULL-YEAR
2022 FINANCIAL RESULTS AND PROVIDE A BUSINESS UPDATE
Source text for Eikon: ID:nPn7yxk3ma
Further company coverage: CMMB.O
Recent news on Chemomab Therapeutics
See all newsBrief: Chemomab Therapeutics Announces Second Quarter 2026 Financial Results And Provides Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview
Israel's Chemomab Q4 net loss narrows on lower R&D spend
Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update